Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Oncology

News · August 23, 2024

Salivary CD44, Total Protein ID Recurrence Risk in Head and Neck Cancer

Higher CD44 and total protein levels linked to increased hazard ratios for recurrence in multivariate adjusted analysis

HealthDay

 

Further Reading